Type 2 diabetes mellitus ICD11 code: 5A11
glibenclamide not suitable above 60 years.
Oral > Solid: 30 mg controlled-release ; 60 mg controlled-release ; 80 mg controlled-release
Adolescents and adults
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup A10BB Sulfonylureas
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that medicines in 4th level ATC chemical subgroup, A10BB Sulfonylureas, be specified as therapeutic alternatives under the square box listing for gliclazide on the EML.